Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Crescent Biopharma, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −3 vs. Q4 2021
- Shares held
- 27.4M
- −2.28M (−7.7%) vs. Q4 2021
- Total value
- $31.2M
- −$11.5M (−26.9%) vs. Q4 2021
- New holders
- 3
- 9 more added
- Sold out
- 6
- 19 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 9,544,262 | $10.9M | 0.44% | 00.0% | Unchanged |
| NEA Management Company, LLC | 9,089,041 | $10.4M | 0.33% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,990,087 | $2.27M | 0.01% | +39,001+2.0% | Added |
| Vanguard Group Inc | 1,814,963 | $2.07M | 0.00% | −423,590−18.9% | Reduced |
| BlackRock Inc. | 868,237 | $990.0K | 0.00% | −4,621−0.5% | Reduced |
| Renaissance Technologies LLC | 470,600 | $536.0K | 0.00% | −130,700−21.7% | Reduced |
| Two Sigma Investments, LP | 420,819 | $480.0K | 0.00% | −189,443−31.0% | Reduced |
| Millennium Management LLC | 404,189 | $461.0K | 0.00% | −287,524−41.6% | Reduced |
| Two Sigma Advisers, LP | 388,800 | $443.0K | 0.00% | −266,000−40.6% | Reduced |
| Geode Capital Management, LLC | 363,437 | $414.0K | 0.00% | −1,669−0.5% | Reduced |
| Dimensional Fund Advisors LP | 271,129 | $309.0K | 0.00% | −293,259−52.0% | Reduced |
| D. E. Shaw & Co., Inc. | 255,684 | $291.0K | 0.00% | −12,187−4.5% | Reduced |
| Federated Hermes, Inc. | 217,116 | $248.0K | 0.00% | −128,336−37.2% | Reduced |
| Franklin Resources Inc | 161,300 | $184.0K | 0.00% | +993+0.6% | Added |
| Bridgeway Capital Management, LLC | 155,400 | $177.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 148,965 | $170.0K | 0.00% | +4,700+3.3% | Added |
| Eversept Partners, LP | 100,579 | $114.7K | 0.01% | +579+0.6% | Added |
| Northern Trust Corp | 97,797 | $111.0K | 0.00% | −690−0.7% | Reduced |
| Susquehanna Fundamental Investments, LLC | 90,876 | $104.0K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 89,926 | $103.0K | 0.00% | −29,469−24.7% | Reduced |
| Intellectus Partners, LLC | 90,500 | $103.0K | 0.03% | +10,000+12.4% | Added |
| Pura Vida Investments, LLC | 87,678 | $100.0K | 0.01% | +87,678 | New |
| Susquehanna International Group, LLP | 47,640 | $54.0K | 0.00% | −217,568−82.0% | Reduced |
| Morgan Stanley | 43,652 | $50.0K | 0.00% | −9,503−17.9% | Reduced |
| Ieq Capital, LLC | 38,363 | $44.0K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 28,004 | $32.0K | 0.00% | +1,830+7.0% | Added |
| Bank of New York Mellon Corp | 26,299 | $30.0K | 0.00% | 00.0% | Unchanged |
| Sigma Planning Corp | 18,000 | $21.0K | 0.00% | +18,000 | New |
| Bank of America Corp | 15,804 | $18.0K | 0.00% | +4,090+34.9% | Added |
| Prentiss Smith & Co Inc | 14,000 | $16.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 12,519 | $14.0K | 0.00% | −83,756−87.0% | Reduced |
| ExodusPoint Capital Management, LP | 10,720 | $12.0K | 0.00% | −18,570−63.4% | Reduced |
| Commonwealth Equity Services, LLC | 10,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Coastal Bridge Advisors, LLC | 10,000 | $11.0K | 0.00% | +10,000 | New |
| Simplex Trading, LLC | 4,119 | $4.00K | 0.00% | −95,183−95.9% | Reduced |
| Hartford Financial Management Inc. | 3,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,992 | $2.00K | 0.00% | −5,280−72.6% | Reduced |
| JPMorgan Chase & Co | 1,468 | $2.00K | 0.00% | +230+18.6% | Added |
| BNP Paribas Arbitrage, SA | 481 | $548 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 32 | $0 | 0.00% | −21,022−99.8% | Reduced |
| Carolinas Wealth Consulting LLC | 395 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 255 | $0 | 0.00% | +1+0.4% | Added |
| FinTrust Capital Advisors, LLC | 245 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 600 | – | – | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −146,078−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −38,533−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −34,903−100.0% | Sold out |
| XR Securities LLC | 0 | $0 | 0.00% | −10,395−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |